Accure is excited to join NVIDIA Inception.

Accure won an AMGEN Golden Ticket.

Accure was awarded a Biogen Golden Ticket.

Accure received a competitive grant from the National Cancer Institute.

Accure's CEO Jessica Sang was featured as a Next Generation Leader in the LabCentral Impact Report.

New publication in Nature Biomedical Engineering demonstrated the potential of Accure's high-throughput EV analysis for detecting colorectal cancer with >96% accuracy.

Accure was named a finalist in the Harvard President’s Innovation Challenge.

Accure's CEO Jessica Sang was invited to join the Forbes Business Council.

Accure joined the BrainMind ecosystem founded by Michael McCullough and Reid Hoffman.

Accure team member summited Mt. Everest and carried Accure's logo flag to the summit.

Accure was selected to join the prestigious Pagliuca Harvard Life Lab.

Accure secured seed funding from premier angel investors.